Curiously, several of these treatments do not affect the expression of DUX4 targets, which are considered intimately linked in FSHD [40,42,87,184,185], raising concern regarding some of the readout currently used in the field. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.